Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Christopher Richard Anzalone. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Christopher Richard Anzalone telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:ARWR / Arrowhead Pharmaceuticals, Inc. Chief Executive Officer, Director 3,921,255
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Christopher Richard Anzalone. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Christopher Richard Anzalone sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-04-11 2025-04-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -50,800 3,921,255 -1.28 11.49 -583,692 45,055,220
2025-04-11 2025-04-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -50,000 3,972,055 -1.24 10.87 -543,500 43,176,238
2025-04-11 2025-04-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,617 4,022,055 -0.04 11.76 -19,016 47,299,367
2025-04-11 2025-04-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -3,400 4,023,672 -0.08 10.75 -36,550 43,254,474
2025-04-11 2025-04-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -35,305 4,027,072 -0.87 9.93 -350,579 39,988,825
2025-03-17 2025-03-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -51,425 4,062,377 -1.25 15.07 -774,975 61,220,021
2025-03-17 2025-03-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 340,000 4,113,802 9.01
2025-03-05 2025-03-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -133,333 3,773,802 -3.41 17.02 -2,269,328 64,230,110
2025-03-05 2025-03-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 133,333 4,073,802 3.38 7.75 1,033,331 31,571,966
2025-03-05 2025-03-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -166,667 3,907,135 -4.09 18.03 -3,005,006 70,445,644
2025-03-05 2025-03-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 166,667 3,940,469 4.42 7.75 1,291,669 30,538,635
2025-02-10 2025-02-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 9,550 3,773,802 0.25 20.10 191,955 75,853,420
2025-01-06 2025-01-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11,520 3,764,252 -0.31 19.05 -219,456 71,709,001
2024-12-23 2024-12-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12,563 3,775,772 -0.33 19.59 -246,109 73,967,373
2024-12-20 2024-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 100,000 3,788,335 2.71
2024-12-20 2024-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,799 3,688,335 -0.16 22.12 -128,274 81,585,970
2024-12-20 2024-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,260 3,694,134 -0.22 21.74 -179,572 80,310,473
2024-12-20 2024-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12,653 3,702,394 -0.34 20.52 -259,640 75,973,125
2024-02-02 2024-01-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -19,730 3,715,048 -0.53 32.71 -645,368 121,519,220
2024-02-02 2024-01-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -37,769 3,734,778 -1.00 32.16 -1,214,651 120,110,460
2024-02-02 2024-01-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 57,499 3,772,547 1.55 14.54 836,035 54,852,833
2024-01-04 2024-01-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,318 3,715,048 -0.14 31.25 -166,188 116,095,250
2024-01-04 2024-01-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,634 3,720,366 -0.12 30.74 -142,449 114,364,051
2023-12-22 2023-12-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12,000 3,725,000 -0.32 28.54 -342,480 106,311,500
2023-10-27 2023-10-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -24,338 3,737,000 -0.65 24.21 -589,223 90,472,770
2023-09-20 2023-09-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -26,232 3,761,338 -0.69 28.27 -741,579 106,333,025
2023-09-20 2023-09-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -31,523 3,787,570 -0.83 28.00 -882,644 106,051,960
2023-09-20 2023-09-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 57,755 3,819,093 1.54 4.75 274,336 18,140,692
2023-05-05 2023-05-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -25,992 3,761,338 -0.69 40.02 -1,040,200 150,528,747
2023-05-05 2023-05-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -24,008 3,787,330 -0.63 38.97 -935,592 147,592,250
2023-05-05 2023-05-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 50,000 3,811,338 1.33 2.01 100,500 7,660,789
2023-05-05 2023-05-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -54,928 3,761,338 -1.44 39.14 -2,149,882 147,218,769
2023-05-05 2023-05-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 54,928 3,816,266 1.46 2.01 110,405 7,670,695
2022-12-20 2022-12-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 234,025 3,720,714 6.71
2022-12-20 2022-12-16 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 18,375 3,486,689 0.53
2022-09-29 2022-09-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X -1,542 3,468,314 -0.04 31.21 -48,126 108,246,080
2022-09-29 2022-09-27 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X -39,082 3,469,856 -1.11 30.77 -1,202,553 106,767,469
2022-07-12 2022-07-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
D - Sale to Issuer -551,197 3,508,938 -13.58
2022-07-11 2022-07-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,501 4,060,135 0.06 14.54 36,365 59,034,363
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy Common Stock)
M - Exercise -146,388 615,033 -19.23
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,900 4,057,634 -0.05 50.51 -95,969 204,951,093
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -61,482 4,059,534 -1.49 50.90 -3,129,434 206,630,281
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -42,153 4,121,016 -1.01 52.28 -2,203,759 215,446,716
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -40,853 4,163,169 -0.97 53.11 -2,169,703 221,105,906
2022-02-14 2022-02-11 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 146,388 4,204,022 3.61 5.19 759,754 21,818,874
2022-01-07 2022-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy Common Stock)
M - Exercise -11,806 761,421 -1.53
2022-01-07 2022-01-07 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,806 4,057,634 0.29 5.19 61,273 21,059,120
2022-01-04 2022-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 800,000 4,045,828 24.65
2021-12-23 2021-12-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy Common Stock)
M - Exercise -11,806 773,227 -1.50
2021-12-23 2021-12-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 11,806 3,245,828 0.37 5.19 61,273 16,845,847
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6,989 3,219,022 -0.22 70.19 -490,558 225,943,154
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9,223 3,226,011 -0.29 69.52 -641,183 224,272,285
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,074 3,235,234 -0.09 68.20 -209,647 220,642,959
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14,857 3,238,308 -0.46 67.19 -998,242 217,581,915
2021-12-17 2021-12-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25,857 3,253,165 -0.79 66.28 -1,713,802 215,619,776
2021-10-22 2021-10-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,830 3,279,022 -0.18 66.09 -385,305 216,710,564
2021-10-22 2021-10-22 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -44,170 3,284,852 -1.33 65.57 -2,896,227 215,387,746
2021-10-22 2021-10-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15,000 3,329,022 -0.45 66.23 -993,450 220,481,127
2021-01-04 2021-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 800,000 3,344,022 31.45
2021-01-04 2020-12-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -599 2,544,022 -0.02
2020-12-30 2020-12-28 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
G - Gift -1,126 2,544,621 -0.04
2020-12-22 2020-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock (right to buy)
M - Exercise -28,274 800,033 -3.41
2020-12-22 2020-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock (right to buy)
M - Exercise -12,236 828,307 -1.46
2020-12-22 2020-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 28,274 2,545,747 1.12 6.15 173,885 15,656,344
2020-12-22 2020-12-18 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 12,236 2,517,473 0.49 4.75 58,121 11,957,997
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -38,676 840,543 -4.40
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -4,003 2,505,237 -0.16 71.61 -286,655 179,400,022
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,880 2,509,240 -0.23 70.87 -416,716 177,829,839
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -12,067 2,515,120 -0.48 69.80 -842,277 175,555,376
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -16,726 2,527,187 -0.66 67.27 -1,125,158 170,003,869
2020-12-10 2020-12-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 38,676 2,543,913 1.54 2.01 77,739 5,113,265
2020-12-10 2020-12-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -16,324 879,219 -1.82
2020-12-10 2020-12-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -16,324 2,505,237 -0.65 67.97 -1,109,542 170,280,959
2020-12-10 2020-12-08 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 16,324 2,521,561 0.65 2.01 32,811 5,068,338
2020-10-23 2020-10-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -12,272 2,505,237 -0.49 58.57 -718,771 146,731,731
2020-10-23 2020-10-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -87,728 2,517,509 -3.37 58.16 -5,102,260 146,418,323
2020-08-14 2020-08-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -50,000 895,543 -5.29
2020-08-14 2020-08-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -50,000 2,605,237 -1.88 41.35 -2,067,500 107,726,550
2020-08-14 2020-08-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 50,000 2,655,237 1.92 9.90 495,000 26,286,846
2020-06-26 2020-06-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -23 2,605,237 0.00 39.55 -910 103,037,123
2020-06-26 2020-06-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -99,977 2,605,260 -3.70 38.81 -3,880,107 101,110,141
2020-01-03 2020-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 900,000 2,705,237 49.85
2019-12-27 2019-12-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -83,333 1,805,237 -4.41 63.50 -5,291,646 114,632,550
2019-12-13 2019-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,393 1,888,570 -0.18 68.18 -231,335 128,762,703
2019-12-13 2019-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -25,412 1,891,963 -1.33 67.30 -1,710,228 127,329,110
2019-12-13 2019-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -45,577 1,917,375 -2.32 66.47 -3,029,503 127,447,916
2019-12-13 2019-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,951 1,962,952 -0.45 65.85 -589,423 129,260,389
2019-12-13 2019-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,379 1,971,903 -0.42 69.41 -581,586 136,869,787
2019-12-13 2019-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -10,343 1,980,282 -0.52 68.51 -708,599 135,669,120
2019-12-13 2019-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -58,059 1,990,625 -2.83 67.31 -3,907,951 133,988,969
2019-12-13 2019-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23,219 2,048,684 -1.12 66.82 -1,551,494 136,893,065
2019-12-04 2019-12-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,022 2,071,903 -0.39 62.00 -497,364 128,457,986
2019-12-04 2019-12-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,011 2,079,925 -0.19 60.73 -243,588 126,313,845
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,656 2,083,936 -0.18 72.95 -266,705 152,023,131
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,800 2,087,592 -0.18 72.13 -274,094 150,578,011
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,448 2,091,392 -0.12 70.72 -173,123 147,903,242
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -6,617 2,093,840 -0.32 69.50 -459,882 145,521,880
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -8,510 2,100,457 -0.40 68.50 -582,935 143,881,304
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -7,193 2,108,967 -0.34 67.63 -486,463 142,629,438
2019-12-04 2019-12-02 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,743 2,116,160 -0.27 66.58 -382,369 140,893,933
2019-10-11 2019-10-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -56,325 945,543 -5.62
2019-10-11 2019-10-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -56,325 2,121,903 -2.59 31.83 -1,792,825 67,540,172
2019-10-11 2019-10-10 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 56,325 2,178,228 2.65 5.20 292,890 11,326,786
2019-09-27 2019-09-25 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -20,000 2,121,903 -0.93 28.25 -565,000 59,943,760
2019-09-24 2019-09-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -66,645 1,001,868 -6.24
2019-09-24 2019-09-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -12,673 2,141,903 -0.59 29.04 -368,024 62,200,863
2019-09-24 2019-09-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -53,972 2,154,576 -2.44 28.00 -1,511,216 60,328,128
2019-09-24 2019-09-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 66,645 2,208,548 3.11 5.10 339,890 11,263,595
2019-09-24 2019-09-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -41,755 1,068,513 -3.76
2019-09-24 2019-09-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -41,755 2,141,903 -1.91 29.04 -1,212,565 62,200,863
2019-09-24 2019-09-23 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 41,755 2,183,658 1.95 5.10 212,950 11,136,656
2019-09-24 2019-09-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -4,250 1,110,268 -0.38
2019-09-24 2019-09-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -4,250 2,141,903 -0.20 29.00 -123,250 62,115,187
2019-09-24 2019-09-20 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4,250 2,146,153 0.20 5.10 21,675 10,945,380
2019-05-29 2019-05-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -9,376 1,133,418 -0.82
2019-05-29 2019-05-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -40,072 1,142,794 -3.39
2019-05-29 2019-05-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 9,376 2,141,903 0.44 2.62 24,565 5,611,786
2019-05-29 2019-05-24 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 40,072 2,132,527 1.92 2.01 80,545 4,286,379
2019-04-05 2019-04-03 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale -50,000 2,092,455 -2.33 19.30 -965,000 40,384,382
2019-01-03 2019-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 600,000 2,142,455 38.90
2018-12-21 2018-12-19 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -90,000 1,542,455 -5.51 13.92 -1,252,800 21,470,974
2018-12-14 2018-12-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common STock
S - Sale X -90,000 1,632,455 -5.23 14.07 -1,266,300 22,968,642
2018-11-09 2018-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -5,300 1,722,455 -0.31 14.95 -79,235 25,750,702
2018-11-09 2018-11-09 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -76,200 1,727,755 -4.22 14.35 -1,093,470 24,793,284
2018-09-05 2018-09-04 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -64,834 1,803,955 -3.47 14.45 -936,851 26,067,150
2018-09-05 2018-08-31 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100,000 1,868,789 -5.08 14.45 -1,445,000 27,004,001
2018-03-16 2018-03-16 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -26,000 1,968,789 -1.30 7.40 -192,400 14,569,039
2018-03-15 2018-03-15 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100,000 1,994,789 -4.77 7.41 -741,000 14,781,386
2018-03-15 2018-03-14 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100,000 2,094,789 -4.56 7.44 -744,000 15,585,230
2018-03-15 2018-03-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
S - Sale X -100,000 2,194,789 -4.36 7.43 -743,000 16,307,282
2018-01-03 2018-01-01 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 500,000 2,294,789 27.86
2017-04-14 2017-04-12 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
A - Award 978,000 1,794,789 119.74
2016-12-15 2016-12-13 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
F - Taxes -300,444 816,789 -26.89 1.27 -381,564 1,037,322
2016-07-05 2016-06-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock Warrant
X - Other -15,772 0 -100.00
2016-07-05 2016-06-30 4 ARWR ARROWHEAD PHARMACEUTICALS, INC.
Common Stock
M - Exercise 15,772 1,117,233 1.43 5.09 80,279 5,686,716
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options
A - Award 80,000 1,166,466 7.36
2016-01-04 2016-01-01 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 540,000 1,101,461 96.18
2016-01-04 2015-12-30 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
F - Taxes -58,712 561,461 -9.47 6.13 -359,905 3,441,756
2015-03-06 2015-03-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options
A - Award 300,000 1,086,466 38.15
2015-03-06 2015-03-04 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 360,000 620,173 138.37
2014-10-15 2014-10-15 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
P - Purchase 16,000 260,173 6.55 6.32 101,120 1,644,293
2014-10-15 2014-10-15 4/A ARWR ARROWHEAD RESEARCH CORP
Common Stock
P - Purchase 16,000 260,173 6.55 6.32 101,120 1,644,293
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Options
A - Award 60,000 786,466 8.26
2014-02-10 2014-02-06 4 ARWR ARROWHEAD RESEARCH CORP
Common Stock
A - Award 210,000 244,173 614.52
2013-09-24 2013-09-21 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 69,991 726,466 10.66
2013-05-08 2013-05-06 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 200,000 656,475 43.81
2012-10-02 2012-09-28 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 50,000 456,475 12.30
2012-02-21 2012-02-16 4 ARWR ARROWHEAD RESEARCH CORP
Stock Option
A - Award 170,000 406,475 71.89
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)